Osteosarcoma – on the way to personalized therapy. Part I: standard chemotherapy in the present
Bone sarcomas account for 7% of malignant tumors in children, and osteosarcomas make up 35–50% of them. Many patients are diagnosed at spread stages of the disease, which dictates the need to search for new approaches to treatment. At the same time, the optimal therapeutic strategy is unknown, the r...
Main Authors: | M. Yu. Rykov, E. R. Senzhapova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2019-05-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/855 |
Similar Items
-
Osteosarcoma – on the way to personalized therapy. Part II: personalized therapy of the future
by: M. Yu. Rykov, et al.
Published: (2019-06-01) -
To the 30th anniversary of the first children’s department of bone marrow transplantation in Russia
by: G. L. Mentkevich
Published: (2021-12-01) -
CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS
by: I. A. Zolotovskayaia, et al.
Published: (2018-03-01) -
Cell technologies as a platform for personalized therapy: global challenges in oncology
by: M. Yu. Rykov, et al.
Published: (2022-08-01) -
Bioresource collection of cell lines and primary tumors of the National Medical Research Center of Oncology of the Ministry of Health of Russia
by: S. V. Timofeeva, et al.
Published: (2022-12-01)